RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karam F. Soliman to Flavonoids

This is a "connection" page, showing publications Karam F. Soliman has written about Flavonoids.
Connection Strength

2.522
  1. Adinew GM, Taka E, Mendonca P, Messeha SS, Soliman KFA. The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer. Nutrients. 2021 Apr 07; 13(4).
    View in: PubMed
    Score: 0.740
  2. Hilliard A, Mendonca P, Russell TD, Soliman KFA. The Protective Effects of Flavonoids in Cataract Formation through the Activation of Nrf2 and the Inhibition of MMP-9. Nutrients. 2020 Nov 27; 12(12).
    View in: PubMed
    Score: 0.722
  3. Zarmouh NO, Messeha SS, Mateeva N, Gangapuram M, Flowers K, Eyunni SVK, Zhang W, Redda KK, Soliman KFA. The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells. Molecules. 2020 May 11; 25(9).
    View in: PubMed
    Score: 0.695
  4. Evans JA, Mendonca P, Soliman KFA. Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases. Nutrients. 2022 May 26; 14(11).
    View in: PubMed
    Score: 0.200
  5. Mendonca P, Darwish AG, Tsolova V, El-Sharkawy I, Soliman KFA. The Anticancer and Antioxidant Effects of Muscadine Grape Extracts on Racially Different Triple-negative Breast Cancer Cells. Anticancer Res. 2019 Aug; 39(8):4043-4053.
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support